With the stock's price at Rs 3222.50, Torrent Pharmaceuticals' performance reflects its position in the pharmaceutical sector.

The rally is being fuelled by solid quarterly results and a string of optimistic fiscal 2026 outlooks from leading drugmakers ...

The drug regulators in the country have reported a significant jump in the number of Not of Standard Quality (NSQ) drug samples in the routine regulatory surveillance activity during the month of ...

Q4 Results May 20, 2025 updates: Find all the latest Q4 results 2025 updates for Hindalco Industries, Torrent Pharmaceuticals, Gland Pharma, Solar Industries India, Dixon Technologies, Whirlpool of ...

Benchmark NSE Nifty50 index ended down 203.75 points at 24609.7, while the BSE Sensex stood down 644.64 points at 80951.99.

AM(IST)on Thursday in a weak market. Zydus Lifesciences Ltd.(up 0.82 per cent), Granules India Ltd.(up 0.61 per cent), Gland ...

Return on investment - most recent fiscal year 19.20 ...

India’s branded pharma market is under pressure as Jan Aushadhi and other generic channels gain momentum, impacting volume ...

The Central Drugs Standard Control Organisation (CDSCO) has flagged 136 batches of pharmaceutical products as Not of Standard ...

An eight-member panel voted unanimously against wider use of Pfizer’s Talzenna in advanced prostate cancer. Elsewhere, U.K.

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company developing therapeutics that use its INTASYL® siRNA gene silencing technology designed to make the body's ...